Basic Information

Drug ID DDPD00768 ...
Drug Name Olopatadine
Molecular Weight 337.4122
Molecular Formula C21H23NO3
CAS Number 113806-05-6
SMILES CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2
External Links
DRUGBANK DB00768
T3DB T3D2886
PubChem Compound 5281071
PDR 1710
Drugs.com Drugs.com Drug Page

Experimental Physicochemical Property

Not Available

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Reference
AUC 9.7 ng.h/ml 9.7±4.4 ng.h/ml ophthalmic administration; normal,healthy; DRUGBANK
AUC 66.0 ng.h/ml 66±26.8 ng.h/ml inhalation, IH; normal,healthy; DRUGBANK
AUC 78.0 ng.h/ml 78.0±13.9 ng.h/ml inhalation, IH; allergic rhinitis; DRUGBANK
Bioavailability 57.0 % 57 % inhalation, IH; normal,healthy; DRUGBANK
C Max 1.6 ng/ml 1.6±0.9 ng/ml ophthalmic administration; normal,healthy; DRUGBANK
C Max 6.0 ng/ml 6.0±8.99 ng/ml inhalation, IH; normal,healthy; DRUGBANK
C Max 23.3 ng/ml 23.3±6.2 ng/ml inhalation, IH; allergic rhinitis; DRUGBANK
T Max 2.0 h 2 h ophthalmic administration; normal,healthy; DRUGBANK
Tss 0.75 h 0.5-1 h inhalation, IH; normal,healthy; DRUGBANK
Tss 1.1 h 0.25-2 h inhalation, IH; allergic rhinitis; DRUGBANK
Clearance 23.5 L/h 23.45 L/h Average clearance; PO, oral; normal,healthy; DRUGBANK
Volume of Distribution 133.8 L 133.83 L normal,healthy; DRUGBANK
Half-life 3.4 h 3.4±1.2 h elimination half-life; ophthalmic administration; DRUGBANK
Half-life 10.0 h 8-12 h elimination half-life; PO, oral; DRUGBANK
Toxicity LD50 1150.0 mg/kg >1150 mg/kg PO, oral; mouse; DRUGBANK
Toxicity LD50 3870.0 mg/kg >3870 mg/kg Rattus, Rat; DRUGBANK
Toxicity TDLo 20.0 mg/kg 20.0 mg/kg PO, oral; Rattus, Rat; DRUGBANK
Toxicity TDLo 0.10 mg/kg 0.1 mg/kg PO, oral; mouse; DRUGBANK
Eliminate Route 70.0 % ~70 % Urinary excretion; PO, oral; DRUGBANK
Eliminate Route 17.0 % ~17 % Faeces excretion; DRUGBANK
Protein Binding 55.0 % ~55 % human, homo sapiens; DRUGBANK

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Brand Name Component Reference
Max dose for children 2.0 drop/day 2 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for children 1.0 drop/day 1 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for children 4.0 sprays/day 4 sprays/day nasal spray Patanol olopatadine hydrochloride PDR
Max dose for children 2.0 drop/day 2 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for children 1.0 drop/day 1 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for children 2.0 sprays/day 2 sprays/day nasal spray Patanol olopatadine hydrochloride PDR
Max dose for children 2.0 drop/day 2 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for children 1.0 drop/day 1 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for children 2.0 sprays/day 2 sprays/day nasal spray Patanol olopatadine hydrochloride PDR
Max dose for adolescents 2.0 drop/day 2 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for adolescents 1.0 drop/day 1 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for adolescents 4.0 sprays/day 4 sprays/day nasal spray Patanol olopatadine hydrochloride PDR
Max dose for adults 2.0 drop/day 2 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for adults 1.0 drop/day 1 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for adults 4.0 sprays/day 4 sprays/day nasal spray Patanol olopatadine hydrochloride PDR
Max dose for geriatric 2.0 drop/day 2 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for geriatric 1.0 drop/day 1 drop/day ophthalmic administration Patanol olopatadine hydrochloride PDR
Max dose for geriatric 4.0 sprays/day 4 sprays/day nasal spray Patanol olopatadine hydrochloride PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1